Skip to content
drillr.ai
Sign up

RYTM

Rhythm Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$102.80
−2.00%
Ask drillr
0
Insider buys (3m)
16
Insider sells (3m)
-$27.4M
Net value (3m)
+18.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 1, 2026Smith Hunter C · officer: Chief Financial OfficerM-Exempt57,187$26
Sep 1, 2026Smith Hunter C · officer: Chief Financial OfficerSale11,514$105
Sep 1, 2026Smith Hunter C · officer: Chief Financial OfficerSale23,072$105
Sep 1, 2026Smith Hunter C · officer: Chief Financial OfficerSale28,188$106
Aug 18, 2026Joshi Manher · officer: Chief Medical OfficerA-Award25,000$0.00
Aug 18, 2026Joshi Manher · officer: Chief Medical OfficerA-Award50,000$115
Aug 17, 2026Shulman Joseph · officer: Chief Technical OfficerSale5,079$120
Aug 17, 2026Garfield Alastair · officer: Chief Scientific OfficerSale800$119
Aug 17, 2026Shulman Joseph · officer: Chief Technical OfficerM-Exempt2,024$6.80
Aug 17, 2026Garfield Alastair · officer: Chief Scientific OfficerSale1,556$117
Aug 17, 2026Garfield Alastair · officer: Chief Scientific OfficerSale3,400$118
Aug 17, 2026Garfield Alastair · officer: Chief Scientific OfficerSale2,007$116
Aug 14, 2026Lee Jennifer Kayden · officer: EVP, Head of North AmericaM-Exempt35,000$24
Aug 14, 2026Mazabraud Yann · officer: EVP, Head of InternationalSale3,605$115
Aug 14, 2026Mazabraud Yann · officer: EVP, Head of InternationalM-Exempt46,625$6.80
Aug 14, 2026Mazabraud Yann · officer: EVP, Head of InternationalSale2,300$112
Aug 14, 2026Lee Jennifer Kayden · officer: EVP, Head of North AmericaSale75,834$117
Aug 14, 2026Mazabraud Yann · officer: EVP, Head of InternationalSale1,000$113
Aug 14, 2026Lee Jennifer Kayden · officer: EVP, Head of North AmericaM-Exempt21,601$6.80
Aug 14, 2026Mazabraud Yann · officer: EVP, Head of InternationalSale14,568$115
Aug 14, 2026Mazabraud Yann · officer: EVP, Head of InternationalSale17,319$117
Aug 14, 2026Mazabraud Yann · officer: EVP, Head of InternationalSale18,208$116
Jul 2, 2026Garfield Alastair · officer: Chief Scientific OfficerM-Exempt4,445$0.00
Jul 2, 2026Garfield Alastair · officer: Chief Scientific OfficerF-InKind2,150$110
Jun 25, 2026Arbuckle Stuart A · directorM-Exempt4,712$0.00
Jun 25, 2026GOOD JENNIFER L · directorM-Exempt4,712$0.00
Jun 25, 2026JEAN CHRISTOPHE · directorA-Award2,324$0.00
Jun 25, 2026MCGIRR DAVID W J · directorA-Award3,691$108
Jun 25, 2026MCGIRR DAVID W J · directorA-Award2,324$0.00
Jun 25, 2026MCGIRR DAVID W J · directorM-Exempt4,712$0.00
Institutional positioning

13F filings over the trailing two quarters

New 127Increased 206Reduced 195Sold out 42
FilerActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.Unchanged6,666,837Aug 14, 2026
RA CAPITAL MANAGEMENT, L.P.Unchanged6,666,837May 15, 2026
BLACKROCK, INC.Reduced6,237,151May 13, 2026
BlackRock, Inc.Reduced6,156,902Aug 7, 2026
BAKER BROS. ADVISORS LPUnchanged5,604,483Aug 14, 2026
BAKER BROS. ADVISORS LPUnchanged5,604,483May 15, 2026
PRIMECAP MANAGEMENT CO/CA/Reduced3,417,509May 11, 2026
PRIMECAP MANAGEMENT CO/CA/Reduced3,168,853Aug 14, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased3,136,895Aug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position3,040,718May 8, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased3,005,977Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2,967,825May 15, 2026
JPMORGAN CHASE & COIncreased2,652,746Aug 12, 2026
PERCEPTIVE ADVISORS LLCIncreased2,586,295Aug 14, 2026
STATE STREET CORPIncreased2,573,529Aug 7, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026